{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:07:32Z","timestamp":1788304052184,"version":"build-2803163510"},"reference-count":59,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glucose, the key source of metabolic energy, is imported into cells by two categories of transporters: 1) facilitative glucose transporters (GLUTs) and 2) secondary active sodium-glucose cotransporters (SGLTs). Cancer cells have an increased demand for glucose uptake and utilisation compared to normal cells. Previous studies have demonstrated the overexpression of GLUTs, mainly GLUT1, in many cancer types. As the current standard positron emission tomography (PET) tracer 2-deoxy-2-(\n                    <jats:sup>18<\/jats:sup>\n                    F)fluoro-D-glucose (2-FDG) for imaging tumour cells via GLUT1 lacks in sensitivity and specificity, it may soon be replaced by the newly designed, highly sensitive and specific SGLT tracer \u03b1-methyl-4-(F-18)fluoro-4-deoxy-Dglucopyranoside (Me-4FDG) in clinical detection and tumour staging. This tracer has recently demonstrated the functional activity of SGLT in pancreatic, prostate, and brain cancers. The mRNA and protein expression of SGLTs have also been reported in colon\/colorectal, lung, ovarian, head, neck, and oral squamous carcinomas. So far, SGLTs have been poorly investigated in cancer, and their protein expression and localisation are often controversial due to a lack of specific SGLT antibodies. In this review, we describe current knowledge concerning SGLT1 and SGLT2 (over)expression in various cancer types. The findings of SGLTs in malignant cells may help in developing novel cancer therapies with SGLT2 or SGLT1\/SGLT2 inhibitors already used in diabetes mellitus treatment.\n                  <\/jats:p>","DOI":"10.2478\/aiht-2018-69-3204","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T04:03:25Z","timestamp":1547179405000},"page":"278-285","source":"Crossref","is-referenced-by-count":41,"title":["Sodium-glucose cotransporters: new targets of cancer therapy?"],"prefix":"10.2478","volume":"69","author":[{"given":"Ivana Vrhovac","family":"Maduni\u0107","sequence":"first","affiliation":[{"name":"Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip","family":"Maduni\u0107","sequence":"additional","affiliation":[{"name":"Division of Molecular Biology, Department of Molecular Biology, Faculty of Science, University of Zagreb, Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davorka","family":"Breljak","sequence":"additional","affiliation":[{"name":"Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Karaica","sequence":"additional","affiliation":[{"name":"Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Saboli\u0107","sequence":"additional","affiliation":[{"name":"Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_001_w2aab3b7b9b1b6b1ab1ab1Aa","unstructured":"1. Vrhovac I, Breljak D, Saboli\u0107 I. Glucose transporters in the mammalian blood cells. Period Biol 2014;116:131-8."},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_002_w2aab3b7b9b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 2013;34:121-38. doi: 10.1016\/j.mam.2012.07.00123506862","DOI":"10.1016\/j.mam.2012.07.001"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_003_w2aab3b7b9b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Wright E. Glucose transport families SLC5 and SLC50. Mol Aspects Med 2013;34:183-96. doi: 10.1016\/j.mam.2012.11.00223506865","DOI":"10.1016\/j.mam.2012.11.002"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_004_w2aab3b7b9b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. Wright E, Loo D, Hirayama B. Biology of human sodium glucose transporters. Physiol Rev 2011;91:733-94. doi: 10.1152\/physrev.00055.200921527736","DOI":"10.1152\/physrev.00055.2009"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_005_w2aab3b7b9b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Hediger M, Rhoads D. Molecular physiology of sodiumglucose cotransporters. Physiol Rev 1994;74:993-1026. doi: 10.1152\/physrev.1994.74.4.993","DOI":"10.1152\/physrev.1994.74.4.993"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_006_w2aab3b7b9b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. Wright EM, Ghezzi C, Loo DDF. Novel and unexpected functions of SGLTs. Physiology 2017;32:435-43. doi: 10.1152\/physiol.00021.2017","DOI":"10.1152\/physiol.00021.2017"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_007_w2aab3b7b9b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol-Endoc M 2010;298:E141-5. doi: 10.1152\/ajpendo.00712.2009","DOI":"10.1152\/ajpendo.00712.2009"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_008_w2aab3b7b9b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. Wright EM, Loo DD, Panayotova-Heiermann M, Lostao MP, Hirayama BH, Mackenzie B, Boorer K, Zampighi G. \u201cActive\u201d sugar transport in eukaryotes. J Exp Biol 1994;196:197-212. PMID: 782302210.1242\/jeb.196.1.1977823022","DOI":"10.1242\/jeb.196.1.197"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_009_w2aab3b7b9b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Otto W. On the origin of cancer cells. Science 1956;123:309-14. doi: 10.1126\/science.123.3191.309","DOI":"10.1126\/science.123.3191.309"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_010_w2aab3b7b9b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Vander Heiden M, Cantley L, Thompson C. Understanding the Warburg effect: the metabolic requiremetns of cell proliferation. Science 2009;324:1029-33. doi: 10.1126\/ science.1160809","DOI":"10.1126\/science.1160809"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_011_w2aab3b7b9b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. Yu L, Chen X, Wang L, Chen S. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget 2016;7:38908-26. doi: 10.18632\/oncotarget.7676","DOI":"10.18632\/oncotarget.7676"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_012_w2aab3b7b9b1b6b1ab1ac12Aa","unstructured":"12. Herrmann K, Benz MR, Krause BJ, Pomykala KL, Buck AK, Czernin J. (18)F-FDG-PET\/CT in evaluating response to therapy in solid tumors: where we are and where we can go. Q J Nucl Med Mol Im 2011;55:620-32. PMID: 22231582"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_013_w2aab3b7b9b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Therapeut 2009;121:29-40. doi: 10.1016\/j. pharmthera.2008.09.005","DOI":"10.1016\/j.pharmthera.2008.09.005"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_014_w2aab3b7b9b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Szablewski L. Expression of glucose transporters in cancers. Biochim Biophys Acta 2013;1835:164-9. doi: 10.1016\/j.bbcan.2012.12.004","DOI":"10.1016\/j.bbcan.2012.12.004"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_015_w2aab3b7b9b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Ouiddir A, Plan\u00e8s C, Fernandes I, VanHesse A, Clerici C. Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells. Am J Resp Cell Mol 1999;21:710-8. doi: 10.1165\/ajrcmb.21.6.3751","DOI":"10.1165\/ajrcmb.21.6.3751"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_016_w2aab3b7b9b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. Zhang J-Z, Behrooz A, Ismail-Beigi F. Regulation of glucose transport by hypoxia. Am J Kidney Dis 1999;34:189-202. doi: 10.1016\/S0272-6386(99)70131-9","DOI":"10.1016\/S0272-6386(99)70131-9"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_017_w2aab3b7b9b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. Baumann MU, Zamudio S, Ilsley N. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am J Physiol-Cell Ph 2007;293:C477-85. doi: 10.1152\/ajpcell.00075.2007","DOI":"10.1152\/ajpcell.00075.2007"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_018_w2aab3b7b9b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. Gorboulev V, Sch\u00fcrmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Saboli\u0107 I, Sendtner M, Koepsell H. Na+-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012;61:187-96. doi: 10.2337\/db11-1029","DOI":"10.2337\/db11-1029"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_019_w2aab3b7b9b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. Wright EM, Turk E. The sodium\/glucose cotransport family SLC5. Pfl\u00fcgers Arch 2004;447:510-8. doi: 10.1007\/s00424-003-1063-6","DOI":"10.1007\/s00424-003-1063-6"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_020_w2aab3b7b9b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. Vallon V. Molecular determinants of renal glucose reabsorption. Focus on \u201cGlucose transport by human renal Na+\/D-glucose cotransporters SGLT1 and SGLT2\u201d. Am J Physiol-Cell Ph 2011;300:C6-8. doi: 10.1152\/ ajpcell.00444.2010","DOI":"10.1152\/ajpcell.00444.2010"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_021_w2aab3b7b9b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. Loo DDF, Wright EM, Zeuthen T. Water pumps. J Physiol 2002;542:53-60. doi: 10.1113\/jphysiol.2002.018713","DOI":"10.1113\/jphysiol.2002.018713"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_022_w2aab3b7b9b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. Saboli\u0107 I, Vrhovac I, Balen Eror D, Gerasimova M, Rose M, Breljak D, Ljubojevi\u0107 M, Brzica H, Sebastiani A, Thal SC, Sauvant C, Kipp H, Vallon V, Koepsell H. Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidneyspecific and exhibits sex and species differences. Am J Physiol-Cell Ph 2012;302:C1174-88. doi: 10.1152\/ajpcell.00450.2011","DOI":"10.1152\/ajpcell.00450.2011"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_023_w2aab3b7b9b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. Vrhovac I, Balen Eror D, Klessen D, Burger C, Breljak D, Kraus O, Radovi\u0107 N, Jadrijevi\u0107 S, Aleksi\u0107 I, Walles T, Sauvant C, Saboli\u0107 I, Koepsell H. Localizations of Na+-Dglucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pfl\u00fcgers Arch 2015;467:1881-98. doi: 10.1007\/s00424-014-1619-7","DOI":"10.1007\/s00424-014-1619-7"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_024_w2aab3b7b9b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. Vrhovac Maduni\u0107 I, Breljak D, Karaica D, Koepsell H, Saboli\u0107 I. Expression profiling and immunolocalization of Na+-D-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats. Pfl\u00fcgers Arch 2017;469:1545-65. doi: 10.1007\/s00424-017-2056-1","DOI":"10.1007\/s00424-017-2056-1"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_025_w2aab3b7b9b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 2010;1:57-92. doi: 10.1007\/s13300-010-0006-4","DOI":"10.1007\/s13300-010-0006-4"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_026_w2aab3b7b9b1b6b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. Kashiwagi Y, Nagoshi T, Yoshino T, Tanaka TD, Ito K, Harada T, Takahashi H, Ikegami M, Anzawa R, Yoshimura M. Expression of SGLT1 in human hearts and impairment of cardiac glucose uptake by phlorizin during ischemiareperfusion injury in mice. PloS One 2015;10:e0130605. doi: 10.1371\/journal.pone.0130605","DOI":"10.1371\/journal.pone.0130605"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_027_w2aab3b7b9b1b6b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. Sharma P, Khairnar V, Vrhovac Maduni\u0107 I, Singh Y, Pandyra A, Salker MS, Koepsell H, Saboli\u0107 I, Lang F, Lang PA, Lang KS. SGLT1 Deficiency turns Listeria infection into a lethal disease in mice. Cell Physiol Biochem 2017:1358-65. doi: 10.1159\/000479197","DOI":"10.1159\/000479197"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_028_w2aab3b7b9b1b6b1ab1ac28Aa","doi-asserted-by":"crossref","unstructured":"28. Kepe V, Scafoglio C, Liu J, Yong WH, Bergsneider M, Huang SC, Barrio JR, Wright EM. Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas. J Neuro-Oncol 2018:138:557-69. doi: 10.1007\/s11060-018-2823-7","DOI":"10.1007\/s11060-018-2823-7"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_029_w2aab3b7b9b1b6b1ab1ac29Aa","doi-asserted-by":"crossref","unstructured":"29. Scafoglio C, Hirayama BA, Kepe V, Liu J, Ghezzi C, Satyamurthy N, Moatamed NA, Huang J, Koepsell H, Barrio JR, Wright EM. Functional expression of sodium-glucose transporters in cancer. P Natl Acad Sci USA 2015;112:E4111-9. doi: 10.1073\/pnas.1511698112","DOI":"10.1073\/pnas.1511698112"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_030_w2aab3b7b9b1b6b1ab1ac30Aa","doi-asserted-by":"crossref","unstructured":"30. Ishikawa N, Oguri T, Isobe T, Fujitaka K, Kohno N. SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn J Cancer Res 2001;92:874-9. doi: 10.1111\/j.1349-7006.2001.tb01175.x","DOI":"10.1111\/j.1349-7006.2001.tb01175.x"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_031_w2aab3b7b9b1b6b1ab1ac31Aa","doi-asserted-by":"crossref","unstructured":"31. Guo GF, Cai YC, Zhang B, Xu RH, Qiu HJ, Xia LP, Jiang WQ, Hu PL, Chen XX, Zhou FF, Wang F. Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis. Med Oncol 2011;28(Suppl 1):S197-203. doi: 10.1007\/s12032-010-9696-8","DOI":"10.1007\/s12032-010-9696-8"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_032_w2aab3b7b9b1b6b1ab1ac32Aa","doi-asserted-by":"crossref","unstructured":"32. Blais A. Expression of Na(+)-coupled sugar transport in HT-29 cells: modulation by glucose. Am J Physiol-Cell Ph 1991;260:C1245-52. doi: 10.1152\/ajpcell.1991.260.6.C1245","DOI":"10.1152\/ajpcell.1991.260.6.C1245"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_033_w2aab3b7b9b1b6b1ab1ac33Aa","doi-asserted-by":"crossref","unstructured":"33. Delezay O, Verrier B, Mabrouk K, van Rietschoten J, Fantini J, Mauchamp J, Gerard C. Characterization of an electrogenic sodium\/glucose cotransporter in a human colon epithelial cell line. J Cell Physiol 1995;163:120-8. doi: 10.1002\/jcp.1041630114","DOI":"10.1002\/jcp.1041630114"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_034_w2aab3b7b9b1b6b1ab1ac34Aa","doi-asserted-by":"crossref","unstructured":"34. Bissonnette P, Gagne H, Coady MJ, Benabdallah K, Lapointe JY, Berteloot A. Kinetic separation and characterization of three sugar transport modes in Caco-2 cells. Am J Physiol 1996;270:G833-43. doi: 10.1152\/ajpgi.1996.270.5.G833","DOI":"10.1152\/ajpgi.1996.270.5.G833"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_035_w2aab3b7b9b1b6b1ab1ac35Aa","doi-asserted-by":"crossref","unstructured":"35. Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 2008;13:385-93. doi: 10.1016\/j.ccr.2008.03.01518455122","DOI":"10.1016\/j.ccr.2008.03.015"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_036_w2aab3b7b9b1b6b1ab1ac36Aa","doi-asserted-by":"crossref","unstructured":"36. Casneuf VF, Fonteyne P, Van Damme N, Demetter P, Pauwels P, de Hemptinne B, De Vos M, Van de Wiele C, Peeters M. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest 2008;26:852-9. doi: 10.1080\/07357900801956363","DOI":"10.1080\/07357900801956363"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_037_w2aab3b7b9b1b6b1ab1ac37Aa","doi-asserted-by":"crossref","unstructured":"37. Hanabata Y, Nakajima Y, Morita K, Kayamori K, Omura K. Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma. Odontology 2012;100:156-63. doi: 10.1007\/s10266-011-0033-2","DOI":"10.1007\/s10266-011-0033-2"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_038_w2aab3b7b9b1b6b1ab1ac38Aa","doi-asserted-by":"crossref","unstructured":"38. Helmke BM, Reisser C, Idzkoe M, Dyckhoff G, Herold- Mende C. Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck. Oral Oncol 2004;40:28-35. doi: 10.1016\/S1368-8375(03)00129-5","DOI":"10.1016\/S1368-8375(03)00129-5"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_039_w2aab3b7b9b1b6b1ab1ac39Aa","doi-asserted-by":"crossref","unstructured":"39. Blessing A, Xu L, Gao G, Bollu LR, Ren J, Li H, Wu X, Su F, Huang W-C, Hung M-C, Huo L, Palapattu GS, Weihua Z. Sodium\/glucose co-transporter 1 expression increases in human diseased prostate. J Cancer Sci Ther 2012;4:306-12. doi: 10.4172\/1948-5956.1000159","DOI":"10.4172\/1948-5956.1000159"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_040_w2aab3b7b9b1b6b1ab1ac40Aa","doi-asserted-by":"crossref","unstructured":"40. Lin H-W, Tseng C-H. A Review on the relationship between SGLT2 inhibitors and cancer. Int J Endocrinol 2014;2014:719578. doi: 10.1155\/2014\/719578","DOI":"10.1155\/2014\/719578"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_041_w2aab3b7b9b1b6b1ab1ac41Aa","doi-asserted-by":"crossref","unstructured":"41. Hummel CS, Lu C, Liu J, Ghezzi C, Hirayama BA, Loo DDF, Kepe V, Barrio JR, Wright EM. Structural selectivity of human SGLT inhibitors. Am J Physiol-Cell Ph 2012;302:C373-82. doi: 10.1152\/ajpcell.00328.2011","DOI":"10.1152\/ajpcell.00328.2011"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_042_w2aab3b7b9b1b6b1ab1ac42Aa","doi-asserted-by":"crossref","unstructured":"42. Vallon V. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med 2015;66:255-70. doi: 10.1146\/annurev-med-051013-110046","DOI":"10.1146\/annurev-med-051013-110046"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_043_w2aab3b7b9b1b6b1ab1ac43Aa","doi-asserted-by":"crossref","unstructured":"43. Balen D, Ljubojevi\u0107 M, Breljak D, Brzica H, \u017dlender V, Koepsell H, Saboli\u0107 I. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Physiol-Cell Ph 2008;295:C475-89. doi: 10.1152\/ajpcell.00180.2008","DOI":"10.1152\/ajpcell.00180.2008"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_044_w2aab3b7b9b1b6b1ab1ac44Aa","unstructured":"44. World Health Organization (WHO). [displayed 22 November 2018]. Available at: http:\/\/www.who.int\/en\/news-room\/factsheets\/detail\/cancer"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_045_w2aab3b7b9b1b6b1ab1ac45Aa","unstructured":"45. RS B, Leung J, Kison P, Zasadny K, Flint A, Wahl R. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med 1999;40:556-65. PMID: 1021021310210213"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_046_w2aab3b7b9b1b6b1ab1ac46Aa","doi-asserted-by":"crossref","unstructured":"46. Kurata T, Oguri T, Isobe T. Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res 1999;90:1238-43. doi: 10.1111\/j.1349-7006.1999.tb00702.x10622535","DOI":"10.1111\/j.1349-7006.1999.tb00702.x"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_047_w2aab3b7b9b1b6b1ab1ac47Aa","doi-asserted-by":"crossref","unstructured":"47. Yu M, Yongzhi H, Chen S, Luo X, Lin Y, Zhou Y, Jin H, Hou B, Deng Y, Tu L, Jian Z. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis. Oncotarget 2015;8:43356-67. doi: 10.18632\/oncotarget.17445","DOI":"10.18632\/oncotarget.17445"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_048_w2aab3b7b9b1b6b1ab1ac48Aa","doi-asserted-by":"crossref","unstructured":"48. Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet 2016;388:73-85. doi: 10.1016\/S0140-6736(16)00141-0","DOI":"10.1016\/S0140-6736(16)00141-0"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_049_w2aab3b7b9b1b6b1ab1ac49Aa","doi-asserted-by":"crossref","unstructured":"49. Ozaki T, Nakagawara A. Role of p53 in cell death and human cancers. Cancers 2011;3:994-1013. doi: 10.3390\/cancers3010994","DOI":"10.3390\/cancers3010994"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_050_w2aab3b7b9b1b6b1ab1ac50Aa","doi-asserted-by":"crossref","unstructured":"50. Ghezzi C, Wright EM. Regulation of the human Na+- dependent glucose cotransporter hSGLT2. Am J Physiol-Cell Ph 2012;303:C348-54. doi: 10.1152\/ajpcell.00115.2012","DOI":"10.1152\/ajpcell.00115.2012"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_051_w2aab3b7b9b1b6b1ab1ac51Aa","doi-asserted-by":"crossref","unstructured":"51. Siegel RL, Miller KD, Jemal A. Cancer Statistics. CA Cancer J Clin 2017;67:7-30. doi: 10.3322\/caac.21387","DOI":"10.3322\/caac.21387"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_052_w2aab3b7b9b1b6b1ab1ac52Aa","doi-asserted-by":"crossref","unstructured":"52. Vaz CV, Marques R, Alves MG, Oliveira PF, Cavaco JE, Maia CJ, Socorro S. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. J Cancer Res Clin Oncol 2016;142:5-16. doi: 10.1007\/s00432-015-1992-4","DOI":"10.1007\/s00432-015-1992-4"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_053_w2aab3b7b9b1b6b1ab1ac53Aa","doi-asserted-by":"crossref","unstructured":"53. Lai B, Xiao Y, Pu H, Cao Q, Jing H, Liu X. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma. Arch Gynecol Obstet 2012;285:1455-61. doi: 10.1007\/s00404-011-2166-5","DOI":"10.1007\/s00404-011-2166-5"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_054_w2aab3b7b9b1b6b1ab1ac54Aa","doi-asserted-by":"crossref","unstructured":"54. Salker MS, Singh Y, Zeng N, Chen H, Zhang S, Umbach AT, Fakhri H, Kohlhofer U, Quintanilla-Martinez L, Durairaj RRP, Barros FSV, Vrljicak P, Ott S, Brucker SY, Wallwiener D, Vrhovac Maduni\u0107 I, Breljak D, Saboli\u0107 I, Koepsell H, Bronsen JJ, Lang F. Loss of endometrial sodium glucose cotransporter SGLT1 is detrimental to embryo survival and fetal growth in pregnancy. Sci Rep 2017;7:12612. doi: 10.1038\/s41598-017-11674-3","DOI":"10.1038\/s41598-017-11674-3"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_055_w2aab3b7b9b1b6b1ab1ac55Aa","doi-asserted-by":"crossref","unstructured":"55. Yu AS, Hirayama BA, Timbol G, Liu J, Basarah E, Kepe V, Satyamurthy N, Huang S, Wright EM, Barrio JR. Functional expression of SGLTs in rat brain. Am J Physiol-Cell Ph 2010;1751:C1277-84. doi: 10.1152\/ajpcell.00296.2010","DOI":"10.1152\/ajpcell.00296.2010"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_056_w2aab3b7b9b1b6b1ab1ac56Aa","doi-asserted-by":"crossref","unstructured":"56. Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang S-C, Wright EM, Barrio JR. Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol-Cell Ph 2013;304:C240-7. doi: 10.1152\/ajpcell.00317.2012","DOI":"10.1152\/ajpcell.00317.2012"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_057_w2aab3b7b9b1b6b1ab1ac57Aa","doi-asserted-by":"crossref","unstructured":"57. Maduni\u0107 J, Vrhovac Maduni\u0107 I, Gajski G, Popi\u0107 J, Garaj- Vrhovac V. Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Lett 2018;413:11-22. doi: 10.1016\/j.canlet.2017.10.041","DOI":"10.1016\/j.canlet.2017.10.041"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_058_w2aab3b7b9b1b6b1ab1ac58Aa","doi-asserted-by":"crossref","unstructured":"58. Koepsell H. The Na+ -D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer. Pharmacol Ther 2017;170:148-65. doi:10.1016\/j.pharmthera.2016.10.017","DOI":"10.1016\/j.pharmthera.2016.10.017"},{"key":"2026051011001487869_j_aiht-2018-69-3204_ref_059_w2aab3b7b9b1b6b1ab1ac59Aa","doi-asserted-by":"crossref","unstructured":"59. Yamazaki Y, Harada S, Tokuyama S. Sodium-glucose transporter as a novel therapeutic target in disease. Eur J of Pharmacol 2018;822:25-31. doi: 10.1016\/j.ejphar.2018.01.003.","DOI":"10.1016\/j.ejphar.2018.01.003"}],"container-title":["Archives of Industrial Hygiene and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/aiht\/69\/4\/article-p278.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/aiht-2018-69-3204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:00:27Z","timestamp":1778410827000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/aiht-2018-69-3204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,1,11]]},"published-print":{"date-parts":[[2018,12,1]]}},"alternative-id":["10.2478\/aiht-2018-69-3204"],"URL":"https:\/\/doi.org\/10.2478\/aiht-2018-69-3204","relation":{},"ISSN":["0004-1254"],"issn-type":[{"value":"0004-1254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}